BPC-157

BPC 157 is a new generation peptide with a high regenerative capacity.
Numerous experiments with his participation indicate its more effective use in the treatment of certain diseases and tissue damage in comparison with such drugs as Bromocriptine or Cimetidine.
BPC-157 goes in vials. Onevial contains 5mg of BPC-157.
BPC 157 is successfully used to treat the mucous membrane of the digestive system, eliminating inflammation and accelerating its healing. Regeneration function of the peptide also performs in regard to bone tissue damage, contributing, for example, to a faster fusion of bones in fractures.
Researches have shown that the drug can be successfully used for violations of the cardiovascular system (restores vascular endothelium), liver and pancreas diseases.
BPC-157 also has neuroprotective effect : the reviews speak of its significant ability to protect nerve cells from damage caused by the toxic effects of certain drugs. This allows the use of the peptide at the same time as certain drugs that have a negative effect on the transmission of nerve impulses.

Mode of administration

BPC-157 peptide is used as an injection. In case of use in diseases of the musculoskeletal system, it is administrated locally. BPC-157 is ideally combined with peptides such as GHRP, GHRH, TB 500, and also with growth hormone. Before using BPC-157 it is advisable to consult with a specialist in order to choose the most optimal dosage.

The dispatch time for this product is 3-4 days.